Ascendis Pharma A/S Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Ascendis Pharma (ASND) Misses Q3 EPS by EUR0.04
November 30, 2016 4:11 PM ESTAscendis Pharma (NASDAQ: ASND) reported Q3 EPS of (EUR0.72), EUR0.04 worse than the analyst estimate of (EUR0.68).
For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.
... More